IO Biotech, Inc. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/eb7157d8-66a3-448e-b290-9cbff43514d0/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-95.5M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-070956 |
| FY 2023 | $-86.1M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-059108 |
| FY 2022 | $-71.5M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-021288 |
| FY 2021 | $-67.9M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-010101 |
| FY 2020 | $-12.0M | 2020-01-01 – 2020-12-31 | evidence 0000950170-22-005244 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).